Learning and research

User account menu

Join
Log in

Main navigation

Upcoming events
Learning and research
IDDI Workstreams & Task Forces
Membership
Pulmonary hypertension
Support us
About us

User account menu

Join
Log in

Breadcrumb

Home
Learning and Research

Pagination

Previous page
Page 6

Related content

GoDeep Global PH Registry
Pulmonary Circulation
Pulmonary Hypertension Global Patient Survey (PH GPS)
Latest news

Fulltext search

Reset filters

Fulltext search

Publication Types

Pulmonary Circulation
IDDI Workstream or Task Force Learning
PVRI Digital Webinar Series
PVRI Community Calls
PVRI 2025 Rio
PVRI 2024 London
PVRI 2023 DDDS
PVRI 2022 Athens

Subjects

Basic research and pathophysiology
- Cellular and molecular biology
- Extra-pulmonary vascular cell and tissue types
- Genetics/genomics and other Omics
- Immunology and inflammation
- Infections and PVD
- Right ventricle
Diagnostic and assessment methods
- 1MWT, 6MWT, Incremental shuttle walk test
- Biomarkers
- Cardiopulmonary exercise test
- Genetic markers
- Hemodynamic assessments
- Imaging techniques
- Pulmonary function test
Diseases and clinical manifestations
- Group 1: Pulmonary Arterial Hypertension (PAH)
- Group 2: PH associated with left heart disease
- Group 3: PH associated with lung disease and/or hypoxia
- Group 4: PH associated with pulmonary artery obstruction / CTEPH
- Group 5: PH with unclear and/or multifactorial mechanisms
- Paediatric PH
Emerging trends and future research
- Emerging therapies
- Novel clinical trial designs in PH
- Policy and guidelines
- Technological advances
Epidemiology and public health
- Global health and PH
- Incidence, prevalence, and risk factors
- Population studies and public health initiatives
Patient care and advocacy
- Advocacy and quality of life improvement
- Palliative care in PH
- Psychosocial aspects and patient education
- Special circumstances
- Symptom management
Treatment
- Perioperative care
- PH-specific therapies
- Special populations
- Supportive therapy
- Surgical and interventional procedures

3 February 2024

Global overview of diagnostics

Presented at PVRI 2024 Congress by Jane Kabwe, National Heart Hospital

Members Only

Member content

3 February 2024

Building high-value health systems: opportunities and challenges

Presented at the PVRI 2024 Congress by Rifat Atun, Harvard University

Members Only

Member content

2 February 2024

Role of TBX4 in neonatal and pediatric developmental lung disease

Presented of PVRI 2024 Congress, by Eric Austin, Monroe Carell Jr. Children's Hospital at Vanderbilt University

PVRI 2024 London

2 February 2024

Screening patients with schistosomiasis associated hepatosplenic disease for PH in Ethiopia and Zambia

An oral presentation delivered at PVRI 2024 Congress by Hanan Yusuf, Addis Ababa University College of Health Sciences

Members Only

Member content

2 February 2024

A global assessment of access to care for patients with PH

An oral presentation delivered at PVRI 2024 Congress by Alexander Kantorovich, United Therapeutics Corporation

Members Only

Member content

2 February 2024

Not just little adults: Clinical update in paediatric PVD

Presented at PVRI 2024 Congress by Nidhy Varghese, Baylor College of Medicine, Texas Children's Hospital

Members Only

Member content

2 February 2024

Building bridges: Shunts and devices to support advanced PH

Presented at PVRI 2024 Congress by Alison Witkin, Massachusetts General Hospital

Members Only

Member content

2 February 2024

Activin signaling inhibitors in PAH

Presented at PVRI 2024 Congress by Marc Humbert, Universite Paris-Saclay

Members Only

Member content

2 February 2024

SGLT2 Inhibitors and Emerging Therapies in HFpEF-PH

Presented at PVRI 2024 Congress by Lisa Mielniczuk, University of Ottawa Institute

Members Only

Member content

2 February 2024

Take a deep breath: Inhalational therapies for group 3 PH

Presented at PVRI 2024 Congress by Oksana Shlobin, Inova Fairfax Hospital

Members Only

Member content

Pagination

First page First

Previous page Previous

…

Page 6

Current page 7

Page 8

Page 9

Next page Next

Last page Last

Footer Menu

GET LEARNING
- Attend an event
- Keep up with PVD developments
GET CONNECTED
GET INVOLVED

Footer menu - pages

Accessibility
Code of Conduct
Complaints
Cookies & Privacy Policy
Social Media Policy
Terms & Conditions

The Pulmonary Vascular Research Institute (PVRI) is a charity registered in England & Wales no. 1127115 and a Company Limited by Guarantee no. 05780068. VAT registration no. 488 0247 66. Registered office: 5 Tanner Street, London SE1 3LE. Phone number: + 44 (0) 7934 126930.

Translate this page